Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients　― A Report From the West Tokyo Heart Failure Registry ―

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

(2022) Paul A. Heidenreich et al.   CIRCULATION

Hospitalization for heart failure: a window of opportunity

(2022) Rolf Wachter et al.   EUROPEAN HEART JOURNAL

Multimorbidity, guideline‐directed medical therapies, and associated outcomes among hospitalized heart failure patients

(2022) Shinsuke Takeuchi et al.   ESC Heart Failure

Optimizing Foundational Therapies in Patients With HFrEF

(2022) Abhinav Sharma et al.   JACC-Basic to Translational Science

Comorbidities complicating heart failure: changes over the last 15 years

(2022) Elles M. Screever et al.   Clinical Research in Cardiology

Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction

(2022) Keiichi Izumi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Virtual optimization of guideline‐directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT‐HF pilot study

(2021) Ankeet S. Bhatt et al.   EUROPEAN JOURNAL OF HEART FAILURE

Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure

(2021) Dennis Grewal et al.   AMERICAN JOURNAL OF CARDIOLOGY

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2021) Theresa A McDonagh et al.   EUROPEAN HEART JOURNAL

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction

(2021) J. F. Nauta et al.   Netherlands Heart Journal

Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study

(2020) Jasper Tromp et al.   Lancet Global Health

Benefit and harm of intravenous vasodilators across the clinical profile spectrum in acute cardiogenic pulmonary oedema patients

(2020) Yasuyuki Shiraishi et al.   European Heart Journal-Acute Cardiovascular Care

Prediction of sudden cardiac death in Japanese heart failure patients: international validation of the Seattle Proportional Risk Model

(2020) Ryoma Fukuoka et al.   EUROPACE

Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients

(2020) Jennifer Cautela et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry

(2020) Hiroki Kitakata et al.   Journal of the American Heart Association

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

(2020) Milton Packer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction

(2020) Akshay S. Desai et al.   JAMA Cardiology

Longitudinal Titration of Medical Therapy for Heart Failure with Reduced Ejection Fraction: CHAMP-HF Registry

(2019) Stephen J. Greene et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case–control analyses

(2019) Mar Martín-Pérez et al.   BMJ Open

Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide

(2018) Yasuyuki Shiraishi et al.   Clinical Research in Cardiology

Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan

(2018) Toshiyuki Nagai et al.   EUROPEAN JOURNAL OF HEART FAILURE

Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists

(2018) Marco Trevisan et al.   EUROPEAN JOURNAL OF HEART FAILURE

Medical Therapy for Heart Failure With Reduced Ejection Fraction

(2018) Stephen J. Greene et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

9‐Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure Registries

(2018) Yasuyuki Shiraishi et al.   Journal of the American Heart Association

Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study

(2018) Tiew-Hwa K Teng et al.   Lancet Global Health

Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

(2018) Gianluigi Savarese et al.   JACC-Heart Failure

Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF

(2017) Michael Böhm et al.   EUROPEAN HEART JOURNAL

Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure

(2017) Dipak Kotecha et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Validation of the Get With The Guideline–Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level

(2016) Yasuyuki Shiraishi et al.   AMERICAN HEART JOURNAL

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes

(2009) Alexandre Mebazaa et al.   CRITICAL CARE MEDICINE

The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies

(2008) SU Yasuda et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS